Status:
COMPLETED
Retinal Therapy Guided by 3D OCT Image Analysis
Lead Sponsor:
Michael Abramoff
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Age-Related Macular Degeneration
Choroidal Neovascularization
Eligibility:
All Genders
45-120 years
Brief Summary
The main purpose is to find a better way to predict the timing of treatments given to patients with Wet Age-related macular degeneration using image analysis.
Detailed Description
The study focuses on making better use of advanced three-dimensional imaging and analysis to allow physicians to know when a treatment is being effective and thus not overuse it. The study will examin...
Eligibility Criteria
Inclusion
- fundoscopically confirmed AMD and patient eligible for treatment with anti-VEGF
Exclusion
- Patients with a CNV due to other causes (OHS, trauma)
- eyes that have been previously treated for CNV
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 5 2018
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT02308215
Start Date
July 1 2010
End Date
July 5 2018
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals Dept of Ophthalmology
Iowa City, Iowa, United States, 52246